Stem Cell Differentiation via Density Gradient and Co-Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing specific types of differentiated cells from stem cells are inefficient and lack control, as they rely on spontaneous differentiation or unspecific stimulation, which is not suitable for therapeutic applications such as tissue regeneration and cancer therapy.
Innovation Solution
A method involving the processing of a core cell population (CCP) to differentiate into a progenitor/precursor cell population (PCP) by stimulating cells extracted from a hematopoietic source, using density gradients and co-culturing with target tissues, and applying specific stimulation factors to achieve controlled differentiation into desired cell types like endothelial cells, neural cells, or cardiomyocytes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If spontaneous differentiation is used to produce differentiated cell cultures, then the culture health is maintained, but the production efficiency of specific cell types is low
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition of the culture medium, altering surface properties of culture dishes, and introducing specific genes to control stem cell differentiation. These parameter modifications enable directed differentiation into specific cell types while maintaining culture health, resolving the contradiction between spontaneous differentiation reliability and production efficiency.
2Manufacturing precision
If co-culturing with target tissues is used to induce differentiation, then specific cell types are produced, but the process complexity increases
Solution Approach 1:
The patent uses co-culturing with target tissues as an intermediary approach to induce differentiation. By placing stem cells in contact with or near target tissues (separated by barriers in some embodiments), the method achieves specific cell type production without direct manipulation of each cell, balancing manufacturing precision with manageable process complexity.
3Manufacturing precision
If density gradient separation is used to isolate stem cells, then cell purity is improved, but the processing time increases
Solution Approach 1:
The patent applies preliminary action by performing density gradient separation early in the process to isolate pure stem cell populations before differentiation. This upfront purification step ensures high cell purity is achieved before subsequent differentiation steps, preventing contamination issues that would require additional time-consuming purification steps later.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient production of specific progenitor cell populations that can mature into desired end cells, such as endothelial cells, retinal cells, or cardiomyocytes, suitable for therapeutic use in tissue regeneration and cancer therapy, with high viability and functional activity.
Implementation Method 1
applying density gradients to separate the core cell population
Implementation Method 2
The process of stem cell differentiation is controlled by internal signals, which are activated by genes within the cell, and by external signals for cell differentiation
Data Source
AI summary
A method is provided, including in vitro stimulating an initiating cell population (ICP) of at least 5 million cells that have a density of less than 1.072 g/ml, and at least 1% of which are CD34+CD45−/dim, to differentiate into a progenitor/precursor cell population (PCP). A method is provided, including in vitro stimulating an initiating cell population (ICP) of at least ten thousand cells that have a density of less than 1.072 g/ml to differentiate into a progenitor/precursor cell population (PCP). A method is provided, including separating lower density cells from higher density cells, the lower density cells defining an initiating cell population (ICP), and in vitro stimulating the ICP to differentiate into a progenitor/precursor cell population (PCP). Other embodiments are also described.